Abstracts Selected for Presentation at 2013 ASTRO Annual Meeting

Published: June 24th, 2013

Category: Uncategorized

Abstracts Selected for Presentation at 2013 Annual Meeting Program Committee of the American Society for Radiation Oncology

Author Name

Abstract Title

Julie Bradley, M.D. Pilot Study of Proton Therapy for Treatment of Regional Lymphatics in Breast Cancer Patients
Curtis Bryant, M.D. Bladder‐Preservation Therapy for Small Cell Carcinoma of the Bladder
Richard Cassidy, M.D. Function Preservation after Conservative Resection and Radiotherapy for Soft Tissue Sarcoma of the Distal Extremity as Evaluated by the Toronto Extremity Salvage Score (TESS)
Kaitlin Christopherson Radiation Therapy for Sinonasal Undifferentiated Carcinoma
Kaitlin Christopherson Factors Impacting Long‐term Local Control in Non‐Metastatic Medulloblastoma
Roi Dagan, M.D. Initial Outcomes from the University of Florida Experience with Stereotactic Ablative Rasiotherapy (SABR) for Oligometastases
Rohan Deraniyagala, M.D. Improving Patient Safety One Error at a Time: Implementing an Electronic Error Reporting System in a Radiation Oncology Clinic
Julie Greenwalt, M.D. Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma
Julie Greenwalt, M.D. Primary Radiation Therapy for Adolescent and Young Adult Patients with Nasopharyngeal Cancer
Randal Henderson, M.D., MBA Early Gastrointestinal Toxicity Outcomes from a Prospective Trial of Accelerated Hypofractionation with Proton Therapy for Prostate Cancer
Tyler Hollen, M.D. Squamous Cell Carcinoma of the Lip: A Retrospective Analysis of the University of Florida Experience
Michael Herman, M.D. Evidence of Efficacy from Radiation Therapy following Surgery for Oral Cavity Squamous Cell Carcinoma
Adam Holtzman, M.D. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer following Cryosurgery or HIFU
Brad Hoppe, M.D., MPH Phase II Study of Consolidative Involved‐Node Proton Therapy in Patients with Hodgkin Lymphoma: Early Outcomes
Brad Hoppe, M.D., MPH Comparative Effectiveness Study of Proton Therapy versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient‐reported Outcomes
Daniel Indelicato, M.D. Incidence and Dosimetric Parameters of Brainstem Toxicity Following Proton Therapy
Whoon Kil, M.D. Patient‐reported Hip Symptoms Following Treatment with Proton Therapy for Prostate Cancer
Thomas Kole, A Dosimetric Comparison of Hypofractionated Passively‐Scattered Proton
Radiotherapy and Stereotactic Body Radiotherapy (SBRT) in the Definitive Treatment of Localized Prostate Cancer
Lisa McGee, M.D. Pulmonary Toxicity Following Proton Therapy for Patients with Non‐Small Cell Lung Cancer
Nancy Mendenhall, M.D. Five‐Year Outcomes of Proton Therapy in Localized Prostate Cancer on Three Prospective Trials for Low‐, Intermediate‐, and High‐Risk Prostate Cancer
Romaine Nichols, M.D. Serum Testosterone Changes in Patients Treated with Radiotherapy Alone for Prostate Cancer on RTOG 9408
Shayna Rich, M.D. Offering and Enrolling Patients in Outcomes Tracking or Clinical Trials
Michael Scott, M.D. Radiotherapy for Hemangiopericytoma
Tamara Smith Grade 3 Genitourinary Toxicities in Men after Proton Therapy for Prostate Cancer
Emily Tanzler, M.D. Meningiomas: A Retrospective Outcomes Analysis of the University of Florida Proton Institute Experience.
Noelle Williams, M.D. Late Effects Following Radiotherapy for Childhood Low‐Grade Glioma
Ross Zeitlin Fiducial Markers, Rectal Saline, and Rectal Balloons as Prostate Localization and Stabilization Strategies in Patients Receiving Proton Therapy